Clinical Trial Update: Impact of Benralizumab Treatment on Circulating Dendritic Cells in Patients With Eosinophilic Asthma [Phase 4]

View source ↗

Summary

Phase 4 trial update studying the impact of benralizumab on circulating dendritic cells in patients with severe eosinophilic asthma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eosinophilic Asthma

Drugs mentioned

• Benralizumab (benralizumab)

Snippet

Sponsor: University of Rostock | Conditions: Severe Eosinophilic Asthma | Phase 4 | Status: UNKNOWN